Orthopedics
Conference Coverage
VIDEO: Biologics: Proposed guideline addresses perioperative management
Biologic agents should be stopped prior to elective total knee or hip arthroplasty in patients with rheumatic diseases, according to a draft...
Conference Coverage
Continue DMARDs, biologics in RA surgery patients
WASHINGTON - The perioperative use of disease-modifying antirheumatic drug monotherapy or combined therapy with methotrexate and tumor necrosis...
From the Journals
Anti–nerve growth factor drug has long-term OA pain benefit, but unclear safety
Treatment for a year with the human anti–nerve growth factor monoclonal antibody fulranumab provided pain relief and functional benefits to...
From the Journals
Silicone joint arthroplasty for RA shows sustained improvements at 7 years
Rheumatoid arthritis patients who underwent silicone metacarpophalangeal joint replacement maintained significant improvement in ulnar drift and...
News
Pain starting in knee later arises in other joints
Key clinical point:People with frequently painful knees often develop pain in joints outside the knee, and the sites vary from person to person....
News
United States an expensive place for knee, hip replacement
News
FDA: New labeling warns against combining opioids, benzodiazepines
Prescription opioid pain or cough medicines and benzodiazepines will now carry the strongest available warning regarding serious side effects and...
Conference Coverage
No VTE prophylaxis needed after joint surgery in patients with hemophilia
Key clinical point: Prophylaxis against thromboembolic events after orthopedic surgery in patients with hemophilia may not be necessary. Major...
Conference Coverage
New fragility fracture recommendations emphasize coordination of care
News
Jury still out on mortality benefits of knee replacement in OA
People with osteoarthritis who go on to have a knee replacement do not appear to have an increased risk of all-cause mortality, but the jury is...